In fact, CD4S and TB1/TB2-specific T cell clones could be the main source of the higher serum levels of IFN-γ observed in patients with COVID-19 and LTBI versus COVID-19 in Rajamanickam et al. The gene discussed is IFNG; the disease is COVID-19.